Actions of Fluorinated Alkanols on GABAA Receptors
- 1 April 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 88 (4), 877-883
- https://doi.org/10.1213/00000539-199904000-00036
Abstract
Previous work demonstrates that various anesthetics enhance the effect of gamma-aminobutyric acid (GABA), and this enhancement has been proposed as an explanation for how anesthetics cause anesthesia. This explanation extends to both fluorinated and unfluorinated alkanols. In the present study, we tested the capacity of fluorinated alkanols to enhance the function of the GABAA receptors expressed in Xenopus oocytes. CF3 CH2 OH, CF3 (CF2)2 CH2 OH and CF3 (CF2)4 CH2 OH potentiated GABAA receptor function, but CF3 (CF2)5 CH2 OH did not. The degree of potentiation decreased in proportion to the chain length of the alkanols. These findings were not specific for receptors expressed in oocytes, as similar results were obtained with muscimol-stimulated36 Cl- uptake using mouse brain membrane vesicles. Although CF3 (CF2)5 CH2 OH has been reported to enhance the capacity of desflurane to produce immobility in vivo, in our in vitro studies, this compound reduced potentiation of GABA-gated response by anesthetics such as isoflurane, enflurane, and pentobarbital. CHF2 (CF2)5 CH2 OH, which has in vivo anesthetic effects, also failed to potentiate GABAA receptor function. These results indicate that the GABAA receptor is not the only receptor affected by fluorinated alkanols and that other receptors contribute to the capacity of alkanols to produce immobility. In particular, CF3 (CF2)5 CH2 OH and CF3 CH2 OH inhibited N-methyl-D-aspartate receptor-mediated responses, which raises the possibility that this receptor is important for actions of fluorinated alkanols. Implications: We find a consistent parallel between the immobilization produced by fluorinated alkanols and their actions on N-methyl-D-aspartate receptors but do not find a consistent parallel between immobilization and effects on gamma-aminobutyric acid type A receptors. Thus, we suggest that N-methyl-D-aspartate, but not gamma-aminobutyric acid type A, receptors may mediate the capacity of anesthetics to produce immobilization. (Anesth Analg 1999;88:877-83)Keywords
This publication has 19 references indexed in Scilit:
- Minimum Alveolar Anesthetic Concentration of Fluorinated Alkanols in RatsAnesthesia & Analgesia, 1999
- Enhancement of Glycine Receptor Function by Ethanol Is Inversely Correlated with Molecular Volume at Position α267Journal of Biological Chemistry, 1998
- Adenoviral‐Mediated Interferon‐γ Gene Therapy Augments Pulmonary Host Defense of Ethanol‐Treated RatsAlcohol, Clinical and Experimental Research, 1998
- Actions of long chain alcohols on GABAa and glutamate receptors: relation to in vivo effectsBritish Journal of Pharmacology, 1996
- Evolutionary history of the ligand-gated ion-channel superfamily of receptorsTrends in Neurosciences, 1995
- Anaesthetic concentrations of alcohols potentiate GABAA receptor-mediated currents: lack of subunit specificityEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Cloning, Functional Coexpression, and Pharmacological Characterisation of Human cDNAs Encoding NMDA Receptor NR1 and NR2A SubunitsJournal of Neurochemistry, 1994
- The Role of the GABAA Receptor/Chloride Channel Complex in AnesthesiaAnesthesiology, 1993
- Importance of a novel GABAA receptor subunit for benzodiazepine pharmacologyNature, 1989
- Extension of AM1 to the halogensJournal of Molecular Structure: THEOCHEM, 1988